相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19
Nishant Shekhar et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2022)
NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase
Oluwafunke R. Kolawole et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination with irinotecan
Cecilia Rodriguez Lanzi et al.
NEOPLASIA (2022)
Repurposing of Medicines in the EU: Launch of a Pilot Framework
Charlotte Asker-Hagelberg et al.
FRONTIERS IN MEDICINE (2022)
Repurposing - second life for drugs
Porkodi Ayyar et al.
PHARMACIA (2022)
Pirfenidone Sensitizes NCI-H460 Non-Small Cell Lung Cancer Cells to Paclitaxel and to a Combination of Paclitaxel with Carboplatin
Helena Branco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Aspirin Suppressed PD-L1 Expression through Suppressing KAT5 and Subsequently Inhibited PD-1 and PD-L1 Signaling to Attenuate OC Development
Xiyun Xiao et al.
JOURNAL OF ONCOLOGY (2022)
Structure-based drug repositioning: Potential and limits
Melissa F. Adasme et al.
SEMINARS IN CANCER BIOLOGY (2021)
Repurposing drugs in oncology: From candidate selection to clinical adoption
Pan Pantziarka et al.
SEMINARS IN CANCER BIOLOGY (2021)
Progress on the Mechanism for Aspirin's Anti-tumor Effects
Lin Zheng et al.
CURRENT DRUG TARGETS (2021)
Differential actions of indomethacin: clinical relevance in headache
Oliver Summ et al.
PAIN (2021)
NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention-Structural Modulation, Mechanisms of Action, and Bright Future
Sandra Ramos-Inza et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Hyaluronic acid (HA)-coated naproxen-nanoparticles selectively target breast cancer stem cells through COX-independent pathways
Eva Espinosa-Cano et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
Tepoxalin increases chemotherapy efficacy in drug-resistant breast cancer cells overexpressing the multidrug transporter gene ABCB1
Jasmine A. McQuerry et al.
TRANSLATIONAL ONCOLOGY (2021)
A Database of Drug Repurposing Clinical Trials in Oncology
Pan Pantziarka et al.
FRONTIERS IN PHARMACOLOGY (2021)
Is drug repurposing really the future of drug discovery or is new innovation truly the way forward?
Carmen Gil et al.
EXPERT OPINION ON DRUG DISCOVERY (2021)
Diclofenac N-Derivatives as Therapeutic Agents with Anti-Inflammatory and Anti-Cancer Effect
Alberto Galisteo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
Rita Rebelo et al.
PHARMACEUTICALS (2021)
Novel Applications of NSAIDs: Insight and Future Perspectives in Cardiovascular, Neurodegenerative, Diabetes and Cancer Disease Therapy
Edmundas Kadusevicius
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Recent Advances in the Synthesis of Ibuprofen and Naproxen
Min-Woo Ha et al.
MOLECULES (2021)
Anticancer effects of non-steroidal anti-inflammatory drugs against cancer cells and cancer stem cells
Keisuke Okamoto et al.
TOXICOLOGY IN VITRO (2021)
Naproxen inhibits spontaneous lung adenocarcinoma formation in KrasG12V mice
Gaurav Kumar et al.
NEOPLASIA (2021)
Network Pharmacology and Experimental Validation Reveal the Effects of Chidamide Combined With Aspirin on Acute Myeloid Leukemia-Myelodysplastic Syndrome Cells Through PI3K/AKT Pathway
Simin Liang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Drug repositioning in cancer: The current situation in Japan
Takaaki Masuda et al.
CANCER SCIENCE (2020)
Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells
Alagesan Seetha et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2020)
Novel approaches to cancer therapy with ibuprofen-loadedEudragit(R)RS 100and/or octadecylamine-modified PLGA nanoparticles by assessment of their effects on apoptosis
Gulsel Yurtdas-Kirimlioglu et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2020)
Anti-Inflammatory Drugs as Anticancer Agents
Silvia Zappavigna et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Drug repositioning: a brief overview
Jean-Pierre Jourdan et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)
Anticancer and Antimicrobial Activities of Naproxen and Naproxen Derivatives
M. Ihsan Han et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2020)
Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
Filipa Moreira-Silva et al.
PHARMACEUTICS (2020)
Cardiovascular effects and safety of (non-aspirin) NSAIDs
Anne-Marie Schjerning et al.
NATURE REVIEWS CARDIOLOGY (2020)
Ibuprofen mediates histone modification to diminish cancer cell stemness properties via a COX2-dependent manner
Wenzhi Shen et al.
BRITISH JOURNAL OF CANCER (2020)
Regulation of Autophagy by Non-Steroidal Anti-Inflammatory Drugs in Cancer
Xiangjie Fu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection
Andreia Palmeira et al.
PHARMACEUTICALS (2020)
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Samik Bindu et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Repurposing old drugs to fight multidrug resistant cancers
Jelena Dinic et al.
DRUG RESISTANCE UPDATES (2020)
Diclofenac Enhances Docosahexaenoic Acid-Induced Apoptosis in Vitro in Lung Cancer Cells
Rosemary A. Poku et al.
CANCERS (2020)
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhe Zhang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
Steven M. Corsello et al.
NATURE CANCER (2020)
Overcoming the legal and regulatory barriers to drug repurposing
Alasdair Breckenridge et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Celecoxib in Cancer Therapy and Prevention - Review
Natalia Toloczko-Iwaniuk et al.
CURRENT DRUG TARGETS (2019)
An update on Drug Repurposing: Re-written saga of the drug's fate
Hema G. N. S. Sree et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Molecular docking of anti-inflammatory drug diclofenac with metabolic targets: Potential applications in cancer therapeutics
Shrish Kumar Pandey et al.
JOURNAL OF THEORETICAL BIOLOGY (2019)
Drug repurposing for antimicrobial discovery
Maya A. Farha et al.
NATURE MICROBIOLOGY (2019)
Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
Patrycja Nowak-Sliwinska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Indomethacin impairs mitochondrial dynamics by activating the PKC-p38-DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells
Somnath Mazumder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Targeting the Shc-EGFR interaction with indomethacin inhibits MAP kinase pathway signalling
Chi-Chuan Lin et al.
CANCER LETTERS (2019)
Diclofenac Potentiates Sorafenib-Based Treatments of Hepatocellular Carcinoma by Enhancing Oxidative Stress
Adrian Paul Duval et al.
CANCERS (2019)
Celecoxib enhances the sensitivity of non-small-cell lung cancer cells to radiation-induced apoptosis through downregulation of the Akt/mTOR signaling pathway and COX-2 expression
Pan Zhang et al.
PLOS ONE (2019)
The first 3500 years of aspirin history from its roots - A concise summary
Maria Rosa Montinari et al.
VASCULAR PHARMACOLOGY (2019)
The molecular targets of diclofenac differs from ibuprofen to induce apoptosis and epithelial mesenchymal transition due to alternation on oxidative stress management p53 independently in PC3 prostate cancer cells
Elif D. Arisan et al.
PROSTATE INTERNATIONAL (2019)
Identifying Drug Repurposing Opportunities in Oncology
Stefania Orecchioni et al.
CANCER JOURNAL (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment
A. B. Nagaraj et al.
ONCOGENE (2018)
Delivering drugs to the lungs: The history of repurposing in the treatment of respiratory diseases
Stephen P. Newman
ADVANCED DRUG DELIVERY REVIEWS (2018)
Ibuprofen reduces cell proliferation through inhibiting Wnt/ catenin signaling pathway in gastric cancer stem cells
Hassan Akrami et al.
CELL BIOLOGY INTERNATIONAL (2018)
Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach
Jaismy P. Jacob et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Pre-clinical effects of metformin and aspirin on the cell lines of different breast cancer subtypes
Maria Eduarda Azambuja Amaral et al.
INVESTIGATIONAL NEW DRUGS (2018)
Celecoxib suppresses proliferation and metastasis of pancreatic cancer cells by down-regulating STAT3/NF-kB and L1CAM activities
Chaohui Zuo et al.
PANCREATOLOGY (2018)
Review of Drug Repositioning Approaches and Resources
Hanqing Xue et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma
Valeria Gerthofer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer
Nathan D. Pennock et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer
Anjana Bhardwaj et al.
BREAST CANCER RESEARCH (2018)
ReDO_DB: the repurposing drugs in oncology database
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2018)
A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac
Fabiola Atzeni et al.
PAIN AND THERAPY (2018)
Formulation and delivery strategies of ibuprofen: challenges and opportunities
Jake Irvine et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2018)
Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
Arnaud Boyer et al.
EUROPEAN RESPIRATORY REVIEW (2018)
Clinical Pharmacology and Cardiovascular Safety of Naproxen
Dominick J. Angiolillo et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2017)
Celecoxib and 2,5-dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β-catenin signaling pathway
Issei Egashira et al.
CANCER SCIENCE (2017)
Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer
Rakesh Dachineni et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
The Drug Repurposing Hub: a next-generation drug library and information resource
Steven M. Corsello et al.
NATURE MEDICINE (2017)
Drug repurposing in cancer
Linda Sleire et al.
PHARMACOLOGICAL RESEARCH (2017)
Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2 and down-regulating the Wnt pathway activity
Chaolin Huang et al.
ONCOTARGET (2017)
On the Integration of In Silico Drug Design Methods for Drug Repurposing
Eric March-Vila et al.
FRONTIERS IN PHARMACOLOGY (2017)
Synthesis and Free Radical-scavenging Activities of Di-mannich Bases of Cyclovalone Derivatives
Hayun Hayun et al.
ORIENTAL JOURNAL OF CHEMISTRY (2017)
Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase
Xiaoyang Dai et al.
CLINICAL CANCER RESEARCH (2017)
Cyclin A2 and CDK2 as Novel Targets of Aspirin and Salicylic Acid: A Potential Role in Cancer Prevention
Rakesh Dachineni et al.
MOLECULAR CANCER RESEARCH (2016)
Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
Roberto Wuerth et al.
DRUG DISCOVERY TODAY (2016)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
In silico methods for drug repurposing and pharmacology
Rachel A. Hodos et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2016)
Proteome-wide prediction of targets for aspirin: new insight into the molecular mechanism of aspirin
Shao-Xing Dai et al.
PEERJ (2016)
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers
Kamal Ahmed et al.
CANCERS (2016)
Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2016)
Drug repositioning and repurposing: terminology and definitions in literature
Joris Langedijk et al.
DRUG DISCOVERY TODAY (2015)
Drug repurposing in oncology-patient and health systems opportunities
Francesco Bertolini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Ibuprofen causes photocleavage through ROS generation and intercalates with DNA: a combined biophysical and molecular docking approach
Mohammed Amir Husain et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2015)
Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular Mechanisms
Verena Leidgens et al.
PLOS ONE (2015)
Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas
Sonam Dilwali et al.
TRANSLATIONAL RESEARCH (2015)
Inhibitory effect of ibuprofen on tumor survival and angiogenesis in gastric cancer cell
Hassan Akrami et al.
TUMOR BIOLOGY (2015)
COMPUTER-AIDED DRUG REPURPOSING: A CYCLOOXYGENASE-2 INHIBITOR CELECOXIB AS A LIGAND FOR ESTROGEN RECEPTOR ALPHA
Enade Perdana Istyastono et al.
INDONESIAN JOURNAL OF CHEMISTRY (2015)
In Vitro Screening for Drug Repositioning
Graeme F. Wilkinson et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Naproxen Induces Cell-Cycle Arrest and Apoptosis in Human Urinary Bladder Cancer Cell Lines and Chemically Induced Cancers by Targeting PI3K
Mi-Sung Kim et al.
CANCER PREVENTION RESEARCH (2014)
Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines
Guangxu Jin et al.
DRUG DISCOVERY TODAY (2014)
Elucidation of the Relationships between H-Bonding Patterns and Excited State Dynamics in Cyclovalone
Marco Lamperti et al.
MOLECULES (2014)
Clinical development success rates for investigational drugs
Michael Hay et al.
NATURE BIOTECHNOLOGY (2014)
Ibuprofen enhances the anticancer activity of cisplatin in lung cancer cells by inhibiting the heat shock protein 70
H. Endo et al.
CELL DEATH & DISEASE (2014)
Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2014)
Targeting apoptosis pathways by Celecoxib in cancer
Verena Jendrossek
CANCER LETTERS (2013)
In silico drug repositioning - what we need to know
Zhichao Liu et al.
DRUG DISCOVERY TODAY (2013)
Validating therapeutic targets through human genetics
Robert M. Plenge et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases
Minna Allarakhia
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: Exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling
Vivek Vaish et al.
BIOMEDICINE & PHARMACOTHERAPY (2012)
Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms
A. Deshpande et al.
LEUKEMIA (2012)
New Uses for Old Drugs: Pharmacophore-Based Screening for the Discovery of P-Glycoprotein Inhibitors
Andreia Palmeira et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2011)
Induction of VEGF by tepoxalin does not lead to increased tumour growth in a canine osteosarcoma xenograft
J. L. Sottnik et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2011)
Recent advances in the investigation of curcuminoids
Hideji Itokawa et al.
Chinese Medicine (2008)
Non-COX-2 targets and cancer: Expanding the molecular target repertoire of chemoprevention
K Kashfi et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Prevention of colorectal cancer using COX-2 inhibitors: Basic science and clinical applications
AJ Chu et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells
J Andrews et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
S Fiorucci et al.
BIOCHEMICAL PHARMACOLOGY (2001)
分享论文
